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ABSTRACT
Background: Seasonal allergic rhinitis (SAR) to Japanese cedar (Cryptomeria japonica; JC) is an IgE-
mediated type I allergy affecting the nasal mucosa. However, the molecular mechanisms that underlie SAR are
only partially understood. The aim of the study was to identify novel genes related to SAR during natural expo-
sure to pollens, by using microarray analysis.
Methods: Subjects were 32 SAR patients and 25 controls. Total RNA was extracted from CD4+ T cells iso-
lated from peripheral blood mononuclear cells and subjected to microarray analysis with Illumina Human Ref8
BeadChip arrays. The Mann-Whitney test was performed to identify genes whose expression was altered dur-
ing allergen exposure. Quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) was
performed on samples collected from SAR patients and controls to verify the microarray results.
Results: Microarray analysis showed that the expression of 3 genes was significantly altered during allergen
exposure. Among these 3 genes, the expression of interleukin 17 receptor beta (IL17RB) was confirmed to be
upregulated in SAR patients compared to that of the IL17RB gene in healthy, non-allergic controls. The aver-
age fold change of IL17RB expression in the real-time RT-PCR experiment was 3.9 (P = 0.003).
Conclusions: The present study identified upregulation of IL17RB during natural allergen exposure in pa-
tients with SAR, which may further elucidate the molecular mechanisms underlying SAR.
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INTRODUCTION
Allergic diseases such as asthma and allergic rhinitis
are major causes of morbidity in developed countries,
and their incidence is increasing. Seasonal allergic
rhinitis (SAR) to Japanese cedar (Cryptomeria japon-
ica) is an IgE-mediated type I allergy affecting the na-
sal mucosa. It is one of the most common allergic dis-
eases in Japan, affecting 19.4% of the Japanese popula-
tion,1 and thus is a major public health issue. Accord-
ing to a national survey, the prevalence of rhinitis in
Japan was 0.16 in 1992 and 0.21 in 2002.2 We recently
reported the prevalence of allergic rhinitis in an adult
population of the Fukui area of Japan was 44.2% (681
of 1,540 subjects aged between 20 and 49 years), and
the most common allergen in allergic rhinitis was
Japanese cedar pollen (89.6%, 610 of 681 subjects with
SAR).3 SAR therefore contributes to the undermining
of quality of life and decline in labor productivity.4
SAR is a chronic, inflammatory disease of the nasal
mucosa caused by the infiltration of lymphocytes,
mast cells, and eosinophils into the nasal mucosa. T-
helper type 2 (Th-2) cytokines play a crucial role in
orchestrating inflammatory responses. However, the
molecular mechanisms that underlie SAR develop-
ment are only partially understood. To understand
the molecular basis of SAR, it would be helpful to ex-
amine the expression of genes in subjects with SAR
during allergen exposure. Microarray techniques per-
mit simultaneous analysis of the expression of many
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Table　1　Characteristics of the study population
SAR (n = 32) Control (n = 25) P value
Age (year ± SD) 36.8±8.8 (25-50) 32.8±7.1 (18-47) 0.052
No. of  Male/Female 16/16 12/13 0.334
Whole blood
Neutrophil (%) 55.2 (range 39.5 to 76.0) 53.7 (range 36.3 to 76.0) 0.596
Lymphocytes (%) 33.7 (range 12 to 48.5) 37.4 (range 16.0 to 57.0) 0.154
Monotytes (%) 5.4 (range 3.3 to 8.0) 5.5 (range 3.6 to 7.3) 0.71
Eosinophils (%) 5.2 (range 0 to 18.0) 2.8 (range 0.3 to 7.3) 0.008
Basophils (%) 0.6 (range 0 to 1.5) 0.6 (range 0 to 1.8) 0.92
Total serum IgE (IU/mL) 50.1 (range 7 to 880) 28.4 (range 5 to 160) 0.049
JC-specifi c IgE (UA/mL) 8.08 (range 0.79 to 86.1) 0.11 (range <0.34 to 0.56) <0.00001
genes. Therefore, large-scale gene expression analy-
sis by microarray may clarify which novel molecules
are related to SAR.
Two types of tissues have been used for human mi-
croarray studies of allergic rhinitis. One is tissue
from the nose, such as nasal polyps and nasal mu-
cosa. Zhang et al.5 performed microarray studies with
nasal mucosa obtained from subjects with and with-
out allergic rhinitis and found that several chemokine
genes such as CC chemokine receptor (CCR) 2,
CCR3, CCR5, CCR8, and CX3 chemokine receptor 1
were highly expressed in the nasal mucosa of sub-
jects with allergic rhinitis compared to the expression
of these genes in the mucosa of subjects without al-
lergic rhinitis.
The other type of tissue is peripheral blood ob-
tained from patients and controls. Larsson et al.6 ex-
amined the transcriptional profiles of dendritic cells
(DCs) after stimulation with grass pollen allergens
and co-culture with autologous CD4+ memory T cells.
This study found a distinct T-cell-induced DC profile
in atopic individuals, suggesting that T cells have a
key instructive role in educating DCs in Th2-type re-
sponses. Benson et al.7 performed microarray analy-
sis using allergen-challenged CD4+ T cells from pa-
tients with SAR and compared the expression level of
CD4+ T cells challenged with diluents only. This
study found that tumor necrosis factor receptor su-
perfamily member 4 (TNFRSF4), which is related to
apoptosis, is significantly upregulated in allergen-
challenged CD4+ T cells. Allergic diseases are
thought to be involved in the dysregulation of T cells,
including CD4+ lymphocytes. Therefore, examining
changes in gene expression levels in CD4+ T cells
from SAR patients and healthy, non-allergic controls
may improve our understanding of the molecular
mechanism underlying SAR.
In the present study, we performed microarray
analysis to identify changes in gene expression that
reflect the status of SAR during natural allergen expo-
sure and found that interleukin 17 receptor B
(IL17RB) is upregulated during natural allergen ex-
posure in SAR patients.
METHODS
SUBJECTS
Between 2003 and 2007, 1575 hospital workers and
university students were invited to participate in an
epidemiological survey of allergic rhinitis. All partici-
pants were of Japanese origin and were residents of
Fukui Prefecture, Japan. The characteristics of the
study population have been described in detail previ-
ously.3 Total and specific IgE (produced in response
to Japanese cedar, Dermatophagoides, Dactylis glom-
erata, Ambrosia artemisiifolia, Candida albicans, and
Aspergillus) were measured using the CAP-RAST
method (Pharmacia Diagnostics AB, Uppsala, Swe-
den).
We invited 56 of the 1575 survey subjects to partici-
pate in a gene expression analysis study and col-
lected a 150-ml blood sample from each subject be-
tween February and April 2009, the time during
which subjects were naturally exposed to Japanese
cedar pollens. We also collected blood samples from
the same individuals between November and Decem-
ber 2008, when they were not exposed to Japanese
cedar pollens. Cases of SAR due to Japanese cedar
polinosis (SAR group) were diagnosed on the basis of
a positive history of rhinitis between February and
April and high levels of Japanese cedar-specific IgE
antibodies in the serum (RAST score  class 2). We
included only those SAR patients who were sensitized
to Japanese cedar (i.e., no detectable allergen-specific
IgE against dust mites, D. glomerata, A. artemisiifo-
lia, C. albicans or Aspergillus; RAST score class 1).
Subjects without allergies (control group) had to sat-
isfy the following criteria: (1) no symptoms or history
of allergic diseases, (2) no detectable, specific IgE an-
tibodies against 6 common inhalant allergens (RAST
score  class 1), and (3) total serum IgE levels be-
low the general population mean. The characteristics
of subjects are listed in Table 1 and Table 2. The sam-
ple from one SAR patient (No. 19) was used only for
realtime RT-PCR analysis because cRNA amplifica-
tion for microarray experiment was not successful.
All participants provided written informed consent
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Table　2　Treatment of SAR patients during natural pollen exposure
Sample No. Age Sex Treatment
2 45 Female Pranlukast
Bepotastine besilate
3 41 Female Epinastine hydrochloride
4 47 Female Epinastine hydrochloride
11 27 Female Olopatadine hydrochloride
12 30 Male No treatment
14 25 Female No treatment
15 28 Female Fexofenadine hydrochloride
19 30 Male Epinastine hydrochloride
23 30 Female No treatment
24 47 Male No treatment
25 27 Male No treatment
30 50 Male Olopatadine hydrochloride
32 49 Female Epinastine hydrochloride
34 31 Male No treatment
36 27 Male No treatment
39 43 Male Cetirizine hydrochloride
40 49 Male No treatment
41 44 Female No treatment
45 45 Male Fexofenadine hydrochloride
53 45 Female Epinastine hydrochloride
55 26 Female Epinastine hydrochloride
56 28 Female Epinastine hydrochloride
57 44 Male Cetirizine hydrochloride
58 37 Male Bepotastine besilate
59 25 Female No treatment
60 25 Female No treatment
65 44 Male Epinastine hydrochloride
68 32 Male Olopatadine hydrochloride
69 45 Female Cetirizine hydrochloride
73 42 Female No treatment
75 38 Male Cetirizine hydrochloride
81 30 Male Bepotastine besilate
Olopatadine hydrochloride
to participate in the study. The study was approved
by the ethical committees of the University of
Tsukuba and the University of Fukui, Japan.
RNA EXTRACTION
Peripheral blood (150 ml) was taken from each sub-
ject. Peripheral blood mononuclear cells (PBMCs)
were purified with Ficoll-PaqueTM gradient (GE
Healthcare, Piscataway, NJ, USA). CD4+ T cells were
isolated from PBMCs with a human CD4 Isolation kit
(Miltenyi Biotec GmbH, Bergisch Gladbach, Ger-
many) according to the manufacturer’s instructions.
RNA was extracted from PBMCs with an RNeasy
Mini Kit (Qiagen K.K., Tokyo, Japan) according to
the manufacturer’s instructions.
We used the Illumina BeadArray with single-color
array (Illumina, San Diego, CA, USA) as a microarray
platform. For the Illumina BeadArray assay, cRNA
was synthesized with an IlluminaⓇ RNA Amplifica-
tion Kit (Ambion, Austin, TX, USA) according to the
manufacturer’s instructions. In brief, 500 ng of total
RNA from CD4+ T cells were reverse transcribed to
synthesize first- and second-strand cDNA, purified
with spin columns, and then in vitro transcribed to
synthesize biotin-labeled cRNA. A total of 750 ng
biotin-labeled cRNA was hybridized to each Illumina
Human Ref8 BeadChip array (Illumina) at 55℃ for 18
h. The hybridized BeadChip was washed and labeled
with streptavidin-Cy3 (GE Healthcare) and then
scanned with the Illumina BeadStation 500 System
(Illumina). The scanned image was imported into
BeadStudio software (Illumina) for analysis. Twenty-
two thousand transcripts representing 8 whole-
genome samples can be analyzed on a single Bead-
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Table　3　Genes related to SAR identifi ed by microarray
Gene Name Description
Microarray Real-time PCR
Accession†Fold 
change q-value
Fold 
change P-value
ARID4B AT rich interactive domain 4B -1.6 0.049 1.1 0.204 NM_016374.5
SERPINE2 serpin peptidase inhibitor, member 2 -1.5 0.049 1 0.104 NM_006216.2
IL17RB interleukin-17 receptor B 1.6 0.049 3.9 0.003 NM_018725.3
†GenBank accession numbers.
Chip. We included at least 1 technical replicate (i.e.,
the same cRNA sample) for each BeadChip. The cor-
relation coefficients for identical RNAs were 0.995 to
0.996 (r2) in the present study.
QUANTITATIVE REAL-TIME REVERSE TRAN-
SCRIPTION-POLYMERASE CHAIN REACTION
(RT-PCR)
CD4+ T cells from the subjects in each group were
purified by Ficoll-PaqueTM gradient (GE Healthcare)
and human CD4 T cell Isolation kit (Miltenyi Biotec
GmbH, Bergisch Gladbach, Germany). The purity of
the isolated CD4 was over 98% in the present study.
Total RNA was extracted from PBMCs with an
RNeasy Kit (Qiagen). Quantitative real-time RT-PCR
was performed with TaqMan Universal Master Mix
and an Assay-on-Demand Gene Expression Kit (Ap-
plied Biosystems, Foster City, CA, USA) according to
the manufacturer’s instructions. The endogenous
control GAPDH was used to normalize the sample
with the ΔΔCT method for relative quantification with
SDS software 2.2.0 (Applied Biosystems).
STATISTICAL METHODS
For the microarray analysis, background-corrected
values for each probe on the BeadChip array were ex-
tracted using BeadStudio version 2.0 (Illumina). The
detection limit corresponding to a 0.01 detection p-
value was determined by using a normal model of in-
tensities of 20 negative control probes that had no
corresponding target in the sample.8 The extracted
values were exported to the software GeneSpring ver-
sion 10 (Silicon Genetics, Redwood, CA, USA), and
per chip and per gene normalizations were per-
formed. The statistical significance of the microarray
data was calculated using the Mann-Whitney test, and
multiple tests were corrected by the Benjamini and
Hochberg false discovery rate.9
Statistical significance of real-time RT-PCR was cal-
culated by using the Wilcoxon signed rank-sum test
(paired samples) and the Mann-Whitney U test (2 in-
dependent samples). In the paired samples, each
sample from SAR patients and controls exposed to
pollens was normalized to the sample from the same
individual not exposed to pollens (sample-specific
normalization). The correlation between normalized
values of the microarray and those of the quantitative
PCR experiments were performed with Spearman’s
rho test. Significance was defined as P < 0.05.
RESULTS
We first selected transcripts that were expressed by
at least half (i.e., 28 samples) of the 56 samples on the
Human Ref8 BeadChip arrays with detection P val-
ues < 0.01. Among the 10,477 expressed transcripts,
those satisfying all the following criteria were se-
lected as up- or downregulated transcripts in the mi-
croarray analysis: (1) more than 1.5-fold increasede-
crease on average and (2) transcripts showing statis-
tically significant differences between the SAR and
control groups (q < 0.05).
A total of 4 transcripts were upregulated, and 15
transcripts were downregulated at the 1.5-fold level
(19 transcripts total). The change in the expression of
3 (12 = up-downregulated) transcripts was statisti-
cally significant (q < 0.05); 1 was up-regulated, and 2
were down-regulated. Genes that were up- and down-
regulated in CD4+ T cells between the SAR and con-
trol groups are listed in Table 3.
We then performed quantitative real-time RT-PCR
to verify the results of the microarray analyses. Sig-
nificant correlations between the microarray results
and the results of the quantitative real-time RT-PCR
were observed for IL17RB (Spearman’s rho = 0.815,
P < 0.0001) and SERPINE2 (Spearman’s rho = 0.877,
P < 0.0001). However, no correlation was observed
for ARID4B (Spearman’s rho = -0.063, P = 0.58). The
average fold change for IL17RB in the real-time RT-
PCR experiment was 3.9 (P = 0.003, Table 3). Al-
though good correlation was observed between the
microarray results and the results of the quantitative
real-time RT-PCR for SERPINE2, the average fold
change for SERPINE2 in the real-time PCR experi-
ment was 1.0 (P = 0.10, Table 3), because of the exis-
tence of outliers.
In the quantitative real-time RT-PCR results of
paired (exposed versus non-exposed) samples,
IL17RB expression was elevated during natural pol-
len exposure in SAR patients but not in the controls
(Fig. 1). IL17RB expression in SAR patients did not
differ from that in controls when they were not ex-
posed to cedar pollens (P = 0.93).
IL17RB Upregulation in Allergic Rhinitis
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Fig. 1　Quantitative real-time RT-PCR validation of microarray data. Each sample from SAR 
patients and control individuals exposed to pollens was normalized to the sample from the same 
individual not exposed to pollens (sample-specific normalization). P values were calculated with 
Wilcoxon signed rank-sum test.
P = 0.009 P = 0.65
ExposedNot exposed ExposedNot exposed
SAR
100
10
1
0.1
0.01
100
10
1
0.1
0.01
Control
DISCUSSION
In the present study, we performed microarray analy-
ses to identify genes related to SAR and identified 3
up- or downregulated genes related to SAR. Among
these 3 genes, IL17RB was confirmed to be upregu-
lated in real-time quantitative PCR analysis.
In our study, the number of genes that were signifi-
cantly altered was small compared with those in
other microarray studies, which used CD4+ cells
stimulated with allergens. One possibility for this dif-
ference is that gene expression change during natu-
ral allergen exposure in vivo is more subtle. Hansel et
al.10 performed microarray analyses using CD4+ T
cells from 84 subjects and did not find a dominant
allergy-associated profile in CD4+ T cells between al-
lergic and non-allergic subjects. Because distinct
CD4+ T-cell-induced DC profiles were reported in
atopic individuals,6 changes in CD4+ T cell profiles
are likely to influence subsequent allergic responses,
leading to the development of SAR.
Microarray experiments are now widely used to si-
multaneously analyze the expression of tens of thou-
sands of genes. Quantitative real-time PCR is a com-
monly used method for validating microarray experi-
ments. However, microarray and quantitative real-
time PCR results sometimes disagree. In general, it
has been reported that correlations increase with in-
creasing degrees of change.11 Dallas and colleagues
reported poorer correlations between microarray ex-
pression scores for genes that exhibited fold-change
differences of <1.5 compared with fold-change differ-
ences of >1.5.12 We observed poor correlation for
ARID4B. The poor correlations may be due, in part,
to the existence of alternative, cross-hybridizing tran-
scripts differentially recognized by the oligonucleo-
tide probe sets and qRT-PCR probes, because several
splice variants exist in ARID4B.
IL-17RB is the receptor for IL-17B and IL-17E (also
known as IL-25).13,14 IL-25 has been shown to induce
Th-2 responses, and recent studies revealed that IL-
17RB was highly expressed on a subset of naive and
activated CD4+ invariant natural killer (NK) T cells,
but not on activated T cells and that IL-17RB+ invari-
ant NKT cells produced large amounts of Th-2 cytoki-
nes that were substantially increased by IL-25 stimu-
lation.15,16 It has also been reported that IL17RB
knockout mice did not exhibit histological signs of
lung inflammation, while marked infiltration of in-
flammatory cells were observed in wild-type mice.17
Recently, Wang et al. performed microarray experi-
ments using PBMCs stimulated with allergens or di-
luents in vitro, and reported that IL17RB was the
most significantly upregulated gene on allergen
stimulation in SAR patients when compared with that
in controls. They also observed a significant increase
in IL17RB gene expression from microarray data of
allergen-challenged CD4 cells from SAR patients as
compared to diluent-challenged cells. This is in
agreement with our findings, which reveal upregula-
tion of IL17RB in SAR patients naturally exposed to
pollens, although the degree of changes in gene ex-
pression that we observed was lower than that in the
study by Wang et al. Therefore, it is speculated that
the differential gene expression pattern of IL17RB in
SAR patients during allergen exposure may be re-
lated to the development of SAR.
In conclusion, the present study identified up-
regulation of IL17RB during natural allergen expo-
sure in patients with SAR. Because the blockade of
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IL-17RB has been reported to prevent IL-25-induced
lung inflammation and Th-2 type cytokine secretion,17
antagonists for IL-17RB could be a novel therapeutic
target for allergic diseases.
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